The recall notice landed on August 21 with clinical precision: 264,842 vehicles, a figure that dwarfs the 103,295 cars XPeng delivered in the entire second quarter. Tesla and eight other manufacturers were swept into the same regulatory action over faulty emergency door release mechanisms, but for XPeng the timing could hardly have been worse.
China’s market regulator SAMR has clearly shifted its posture. An industry that spent years sprinting for market share is now being forced to answer for quality lapses that once went unnoticed. The scale of this particular campaign — a record for the sector — suggests the era of unchecked growth is officially over.
The Numbers That Don’t Quite Add Up
XPeng’s second-quarter results, released this week, present a study in contradiction. Revenue of 19.74 billion yuan and a gross margin of 20.7 percent look respectable on paper. Overseas deliveries jumped 81 percent and accounted for a quarter of first-half revenue. Yet the company still posted a net loss of 1.34 billion yuan for the quarter, and the first-half picture is starker still: a 3.12 billion yuan net loss on 32.78 billion yuan in revenue, or 6.54 yuan per share.
The market’s response was swift — shares fell 5.4 percent on the earnings release. The culprit appears to be guidance. XPeng’s third-quarter outlook of 115,000 to 121,000 deliveries and revenue between 21.7 billion and 23.4 billion yuan came in below what analysts had penciled in. Reuters has pointed to this softer forecast as the primary driver of the recent share price slide, with intensifying competition among China’s EV makers squeezing margins even for established players.
At home, the picture is equally mixed. The Mona L05 line, which moved 165,977 units in the first half, still saw sales decline 15.8 percent year-over-year — a reminder that even popular models are not immune to the broader pricing war.
A Robotics Rescue — or a Distraction?
While the core business wrestles with recalls, margin pressure and lukewarm guidance, XPeng’s leadership is directing capital elsewhere. The company’s robotics division has raised over $900 million in its first funding round, valuing the unit at more than $6.3 billion. IDG Capital led the round, with Tencent and Alibaba participating as strategic investors — a roster that lends credibility to the venture.
The founder himself reportedly put in around $100 million of his own money. That is a genuine commitment, not a token gesture.
Should investors sell immediately? Or is it worth buying XPeng?
But here is where the story gets complicated. XPeng is hardly alone in chasing this opportunity. BYD, Chery, Changan, GAC, Li Auto, SAIC and Seres are all developing their own humanoid robots. China expects roughly 50,000 humanoid robot deliveries in 2026 — a 316 percent jump from the prior year — and accounts for an estimated 97 percent of global sales. When virtually every automaker piles into the same segment, a supposed differentiator quickly becomes an arms race.
The CEO of Unitree Robotics, one of China’s most prominent robotics firms, has cautioned that the industry’s “ChatGPT moment” could still be a decade away. That sobering assessment puts the near-term monetization potential of XPeng’s robotics bet into perspective.
Reading the Tape
The share price tells its own story of ambivalence. On Friday, the stock closed at €9.96, up 2.4 percent on the day — a modest bounce that does little to alter the broader trajectory. The shares remain down 45 percent year-to-date and roughly 59 percent below their November 12 high. They sit just 5.7 percent above the 52-week low touched on August 25, with the 200-day moving average still more than 31 percent above the current price.
That persistent downward drift over months, rather than days, signals a market that has already priced in considerable skepticism. The recall itself is unlikely to cause lasting operational damage — emergency release issues have become almost routine across the industry, as the breadth of the SAMR action demonstrates. But the structural pressures are harder to dismiss.
Two Expensive Bets, No Certainty
XPeng is effectively wagering on two fronts simultaneously: international expansion of its core auto business and humanoid robotics as a future growth engine. Both are costly. Both remain unproven. The overseas numbers are genuinely impressive, yet the persistent net losses and underwhelming guidance suggest the foundational business has not achieved profitable scale.
The robotics funding round represents a meaningful vote of confidence from sophisticated investors. But with nearly the entire Chinese auto industry competing in the same space, and leading robotics executives themselves acknowledging that the breakthrough moment remains years away, this division looks more like a long-term option than a near-term catalyst.
For now, XPeng’s story is one of a company managing two narratives at once — one rooted in the hard realities of China’s brutal EV price war, the other in the speculative promise of embodied AI. The market has clearly decided which one it believes.
Ad
XPeng Stock: Buy or Sell?! New XPeng Analysis from August 30 delivers the answer:
The latest XPeng figures speak for themselves: Urgent action needed for XPeng investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 30.
XPeng: Buy or sell? Read more here...
